In 2017, Neelakantan and colleagues first systematically characterized 5amino1mq during screening for selective NNMT inhibitors, with findings published in Biochemical Pharmacology - marking the official discovery and public reporting of the compound.Through structural modification of quinolinebased precursors, the team identified 5amino1mq as a small, membranepermeable molecule with the chemical formula CHN.With an extremely low IC value, it became one of the most promising selective NNMT inhibitors available at the time, with high specificity and no significant inhibition of other metabolically relevant enzymes
To get a prescription, talk to a healthcare provider
Primary Mechanism: Selective NNMT Inhibition and NAD+ Restoration
This duration balances therapeutic benefits with manageable treatment commitment and cost considerations
Reviewed by the PeptideMind Team Updated July 6th, 2026 Free Peptide Blend Calculator Calculate exact draw volumes for peptide blends, stacks, and custom multi-peptide preparations
